Statins cannot touch it. Neither can diet or exercise. Lipoprotein(a), a cholesterol-like particle hardwired into a person’s ...

GLP-1 drugs reduce heart attacks, strokes, and death risk in trials. Benefits appear even without diabetes, suggesting direct ...

A case-control study revealed that combinations of drugs for cardiovascular diseases and hypertension were frequently prescribed before a diagnosis of bullous pemphigoid (BP), but the risk associated ...

GLP-1 weight loss drugs containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with ...

Pulmonary arterial hypertension, a disease that leads to worsening lung and heart problems that eventually become life-threatening, is treated with drugs that alleviate symptoms. FDA approval of a new ...

Two new studies suggest GLP-1 receptor agonists may reduce heart failure and mortality risks in high‑risk heart procedures, while a Medicare pilot to expand access to these drugs for weight loss has ...

Stopping or interrupting treatment with GLP-1 medications — commonly used for weight loss and for treating diabetes — has been linked to a significant increase in risk for major cardiovascular events, ...